Comparative safety of futibatinib vs pemigatinib in metastatic cholangiocarcinoma: FAERS-based analysis

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

RocScholar (Rochester Regional Health)

redirect
Last time updated on 24/01/2026

This paper was published in RocScholar (Rochester Regional Health).

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.